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Encouraging (Not Discouraging)
Optimal Care for All ST-Segment
Elevation Myocardial
Infarction Patients*
Karl B. Kern, MD
Tucson, Arizona
In this issue of JACC: Cardiovascular Interventions, Ellis et al.
1) present an enhanced ST-segment elevation myocardial
nfarction (STEMI) risk adjustment algorithm that better
ccounts for noncardiac causes of mortality after primary
ercutaneous intervention. The investigators note that in
ontemporary interventional practice, noncardiac issues are
ajor factors affecting post–percutaneous coronary interven-
ion (PCI) outcomes. More than 50% of post-procedural
eaths result from these noncardiac comorbidities.
See page 442
The investigators persuasively argue that current risk
assessment for patients undergoing PCI would be greatly
enhanced by incorporating certain noncardiac comorbidities
into our current algorithms. This is a crucial and much-
needed step if the present systems for public disclosure of
quality and outcome data are to be accurate and allow
meaningful comparisons.
They specifically highlight STEMI patients resuscitated
from sudden cardiac death as a subgroup whose post-PCI
mortality is high and is greatly influenced by noncardiac
factors, namely coincident neurological injury. Appropriate
risk adjustment of expected mortality for such patients
undergoing emergent primary PCI is a crucial step whose
time has clearly arrived.
Patients suffering cardiac arrest with their STEMI have
been systematically excluded in nearly all randomized clin-
ical trials (2–4). Their exclusion emphasizes the recognition
that such patients, even with successful reperfusion of their
infarct artery, are at high risk for increased mortality when
*Editorials published in JACC: Cardiovascular Interventions reflect the views of the
uthors and do not necessarily represent the views of JACC: Cardiovascular Interven-
ions or the American College of Cardiology.
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cardiac arrest (5). Only recently have some in the interven-
tional cardiology community begun to offer such patients
standard timely reperfusion therapy (primary PCI). Unfor-
tunately, such operators and medical centers have found
themselves more often penalized than rewarded for their
efforts to provide optimal cardiovascular care for such
patients. That penalty is manifested in public scorecards,
where their reported mortality rates may be substantially
higher than for operators or centers that do not provide
timely reperfusion for these very sick patients.
The important questions are:
1. Should STEMI patients resuscitated from cardiac arrest
be treated aggressively with emergent reperfusion similar
to STEMI patients who have not suffered cardiac arrest?
Does aggressive cardiac care improve the outcome in
these patients with other major noncardiac risks for
mortality?
2. Should the same goals, including door-to-balloon times
of 90 min, be extended to post-resuscitated STEMI
patients, regardless of their acute neurological status?
3. How can appropriate risk stratification and outcome
expectations for the high-risk STEMI patient be incor-
porated into current public reporting of clinical outcomes?
Though no randomized data exist, clinical reports involv-
ng more than 1,600 post-resuscitated STEMI patients
ave suggested that timely reperfusion does improve out-
ome. Compared with well-documented historical survival
ates of only 25% to 35% for out-of-hospital cardiac arrest
atients, those with concurrent STEMI treated with early
eperfusion (i.e., primary PCI) have a mean survival rate
f 65% (5–22). Importantly, early reperfusion combined
ith the induction of mild systemic hypothermia results
n excellent neurological function in most such survivors
23–28).
No data are available concerning door-to-balloon times in
he post-resuscitated STEMI patient, but logic suggests
hat reperfusion in this critically ill subgroup cannot be
elayed (compared with those STEMI patients not suffer-
ng cardiac arrest), without compromising the benefit of
uch therapy. Hence, the previously common approach of
aiting until good neurological recovery can be ensured
efore intervention and reperfusion of the infarct artery
isses the mark. A better approach is aggressive and timely
eperfusion therapy for these, the sickest, of the STEMI
opulation. Such an approach doubles survival, with more
han 80% of such survivors having excellent long-term
eurological function. Nonetheless, even when survival is
oubled with acute reperfusion, the mortality rate in this
ick subgroup is still 30% to 40%. This is greater than 10
he expected mortality rate for reperfused STEMI patients
ho have not had precedent cardiac arrest. Currently accepted
efinitions used for interhospital mortality comparison do
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450not yet risk adjust to this degree because they ignore these
noncardiac comorbidities. The enhanced predictive model
for post-PCI mortality proposed by Ellis et al. (1) reported
in this issue of JACC: Cardiovascular Interventions could
help this imbalance, but as these investigators note, even
their model is challenged by patients at the highest decile of
risk “(e.g., the 0.5% of all patients undergoing ‘salvage’
procedures with a 44% mortality).” They suggest that
“perhaps such patients should be excluded from scorecard-
ing altogether.” White and McMullan (29) spoke out
similarly when they called for “compassionate use” PCI in
STEMI patients resuscitated from cardiac arrest. These
recognized interventional experts suggested that outcomes
from post-resuscitated STEMI patients undergoing emer-
gency PCI for reperfusion should not be included in overall
mortality statistics for hospitals or individual operators.
They even argued that medical centers willing to provide
primary PCI for such patients should be highlighted as
“Centers of Excellence,” rather than inaccurately labeled as
poorly performing PCI centers because of increased mor-
tality rates when compared with peers not providing such
care to the victims of cardiac arrest.
Ellis et al. (1) highlight with their report that current
public reporting of mortality data for PCI does not ade-
quately adjust for this highest risk subgroup. Intervention-
alists willing to provide the best possible outcomes for those
suffering cardiac arrest with their STEMI are penalized
with higher than expected mortality rates, whereas their
peers who avoid intervention in such high-risk patients are
“rewarded” statistically for withholding potentially benefi-
cial care. This is the exact opposite of what is needed for
optimal patient care.
Unfortunately, the most recent STEMI guidelines say
nothing about this increasingly important impediment to
providing the best care for all STEMI patients (30). It is
time for all influential cardiovascular societies—the Amer-
ican College of Cardiology, the American Heart Associa-
tion, and the Society of Cardiovascular Angiography and
Interventions—to step up and deal with this issue. Provid-
ing operators and medical centers the opportunity to do
what is best for the individual STEMI patient, without fear
of unfair inflation of their overall reported mortality figures,
could greatly influence the outcome of the 25,000 STEMI
patients per year who suffer concurrent cardiac arrest. More
routine aggressive therapy should double the historical
survival rate from 35% to 70%, resulting in 10,000 addi-
tional lives being saved each year! The initial experience
with combining primary PCI with mild therapeutic hypo-
thermia for those cardiac arrest STEMI victims still coma-
tose on arrival at the hospital suggests that 80% of these
survivors should have normal neurological function. Such a
change cannot come too soon.Reprint requests and correspondence: Dr. Karl B. Kern, Depart-
ment of Medicine, Cardiac Catheterization Laboratories, University
of Arizona, Sarver Heart Center, Tucson, Arizona 85724. E-mail:
kernk@email.arizona.edu.
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